HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data-Reference-Cited by-同舟云学术

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

Published:2011-11 Issue:12 Volume:12 Page:1134-1142
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Leo Angelo Di,Desmedt Christine,Bartlett John M S,Piette Fanny,Ejlertsen Bent,Pritchard Kathleen I,Larsimont Denis,Poole Christopher,Isola Jorma,Earl Helena,Mouridsen Henning,O'Malley Frances P,Cardoso Fatima,Tanner Minna,Munro Alison,Twelves Chris J,Sotiriou Christos,Shepherd Lois,Cameron David,Piccart Martine J,Buyse Marc

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer;Muss;N Engl J Med,1994

2. erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer;Paik;J Natl Cancer Inst,1998

3. HER2 and choice of adjuvant chemotherapy for invasive breast cancer: national surgical adjuvant breast and bowel project protocol B-15;Paik;J Natl Cancer Inst,2000

4. HER2 and responsiveness of breast cancer to adjuvant chemotherapy;Pritchard;N Engl J Med,2006

5. Amplification and deletion of topoisomerase II alpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer;Järvinen;Am J Pathol,2000

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy;Clinical Breast Cancer;2024-08

2. Spatial gene expression at single-cell resolution from histology using deep learning with GHIST;2024-07-04

3. Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients;npj Breast Cancer;2023-09-30

4. Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis;European Journal of Cancer;2023-09

5. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials;The Lancet;2023-04